Cancer Family
Liver Epithelial Neoplasm
CI-CAN-00000217Explore in graph →
Non-malignant784 active trials14 approved drugs17 evidence items
- NCIt
- C7106
Loading cancer entity…
Cancer Family
CI-CAN-00000217Explore in graph →
Clinical trials
3,369 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06590844 | "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma | unknown | Phase 4 | 37 | Anhui Provincial HospitalOTHER_GOV | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06417606 | Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma | unknown | Phase 4 | 20 | Zhiyong HuangOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05124002 | Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma | unknown | Phase 4 | 66 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT06003673 | A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC | unknown | Phase 4 | 20 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT05670561 | Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma | unknown | Phase 4 | 60 | The Second Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05416073 | Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma(TACE-HAIC) | unknown | Phase 4 | 70 | The Second Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Feb 24, 2023 | clinicaltrials |
| NCT05113290 | Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment | unknown | Phase 4 | 66 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jan 27, 2022 | clinicaltrials |
| NCT04127396 | Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT | unknown | Phase 4 | 72 | Beijing Ditan HospitalOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT02504983 | Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma | unknown | Phase 4 | 200 | Chang Gung Memorial HospitalOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT01451658 | A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) | unknown | Phase 4 | 100 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 4, 2019 | clinicaltrials |
| NCT01970748 | Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices(P-HCC) | unknown | Phase 4 | 200 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Aug 30, 2019 | clinicaltrials |
| NCT02733809 | Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 4 | 40 | King Saud UniversityOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT03996681 | TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma | unknown | Phase 4 | 22 | Suzhou Municipal HospitalOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT02138981 | Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 4 | 436 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03518502 | Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis | unknown | Phase 4 | 130 | Korea UniversityOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT03515369 | Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma | unknown | Phase 4 | 459 | Eastern Hepatobiliary Surgery HospitalOTHER | 0 | May 3, 2018 | clinicaltrials |
| NCT02525380 | Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 4 | 30 | Seoul National University HospitalOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT02729506 | Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma | unknown | Phase 4 | 150 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT02631499 | Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation | unknown | Phase 4 | 256 | Fudan UniversityOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02534961 | Prophylactic Antibiotics Before RFA for HCC | unknown | Phase 4 | 600 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Aug 28, 2015 | clinicaltrials |
| NCT02535117 | Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC | unknown | Phase 4 | 216 | Sun Yat-sen UniversityOTHER | 0 | Aug 28, 2015 | clinicaltrials |
| NCT02399033 | Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy | unknown | Phase 4 | 1,000 | Shuqun ChengOTHER | 1 | Mar 26, 2015 | clinicaltrials |
| NCT02308319 | Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load(POWER) | unknown | Phase 4 | 124 | Samsung Medical CenterOTHER | 0 | Dec 4, 2014 | clinicaltrials |
| NCT02253511 | A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma | unknown | Phase 4 | 400 | Zheng DonghaiOTHER_GOV | 1 | Oct 1, 2014 | clinicaltrials |
| NCT01997957 | A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC(SOON) | unknown | Phase 4 | 110 | Zhu XuOTHER | 1 | Nov 28, 2013 | clinicaltrials |
| NCT01894269 | Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication | unknown | Phase 4 | 200 | Sun Yat-sen UniversityOTHER | 1 | Jul 23, 2013 | clinicaltrials |
| NCT01438437 | Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis | unknown | Phase 4 | 54 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01570075 | Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria | unknown | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT01415063 | Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma | unknown | Phase 4 | 120 | Sun Yat-sen UniversityOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT01298284 | A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol | unknown | Phase 4 | 60 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Jun 15, 2011 | clinicaltrials |
| NCT01351194 | Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm | unknown | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | May 26, 2011 | clinicaltrials |
| NCT01102335 | Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy(TACEHBV) | unknown | Phase 4 | 80 | Fudan UniversityOTHER | 1 | Apr 13, 2010 | clinicaltrials |
| NCT00834860 | Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma | unknown | Phase 4 | 179 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Feb 15, 2010 | clinicaltrials |
| NCT00555334 | Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma(LAM-RFA) | unknown | Phase 4 | 200 | Sun Yat-sen UniversityOTHER | 1 | Apr 1, 2009 | clinicaltrials |
| NCT00554905 | Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma(RFA and TACE) | unknown | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | Feb 10, 2009 | clinicaltrials |
| NCT00768157 | Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma | unknown | Phase 4 | 200 | Sun Yat-sen UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00556803 | TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma(TACE-RFA) | unknown | Phase 4 | 120 | Sun Yat-sen UniversityOTHER | 1 | Nov 18, 2008 | clinicaltrials |
| NCT00557024 | Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma(RT-RFA) | unknown | Phase 4 | 80 | Sun Yat-sen UniversityOTHER | 1 | Nov 18, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Sep 19, 2024source: clinicaltrials